A genomic surveillance study identified several multidrug-resistant, high-risk clones of E Coli and Klebsiella pneumoniae in ...

The US FDA has approved Iterum Therapeutics' NDA for ORLYNVAH to treat uncomplicated urinary tract infections (uUTIs).

E. coli is the most common cause of blood poisoning, accounting for about one third of cases in the UK, with ESBL strains ... usually via urinary tract infections, cause serious infections.

Objective: To describe clinical response and microbiologic cure rates associated with ertapenem as first-line treatment of infections caused by ESBL-producing organisms. Methods: This case series ...

Dominance of ST131, B2, blaCTX-M-15, and papA-papC-kpsMII-uitA among ESBL Escherichia coli isolated from bloodstream ... seeds through combination treatment with plasma, vacuum packaging, and ...